Clinical & Laboratory Perspectives on HIT and APS

Pre-Congress Course, Wednesday, 18 September 9:00-12:00
Sune Bergsstöm Aula

Register here. Lunch included

Key Learning Objectives:

  • Current Diagnostic Strategies: Understanding the latest algorithms for HIT and APS.
  • Laboratory Methodologies: Insights into specialized testing and modern techniques.
  • Interpretation of Results: Navigating challenges and pitfalls in complex findings.
  • Clinical Management: Translating laboratory data into effective patient care.
  • Clinical-Laboratory Interplay: Enhancing collaboration between clinicians and the lab.

Antiphospholipid Syndrome (APS)

  • Laboratory diagnostics and assessment / Maria Farm
    Current laboratory approaches in APS, including antiphospholipid antibody testing, analytical considerations, interpretation of laboratory profiles, and current challenges in diagnostic classification and clinical correlation.
  • Clinical perspectives and management / Natali Karandyszowska
    Clinical manifestations and diagnostic evaluation of APS, with focus on thrombotic complications, risk stratification, and current therapeutic management strategies.
  • Interactive discussion and case-based reflections
    Interactive session featuring clinical case discussions and deep dives into the complex interplay between laboratory findings and clinical decision-making.

Heparin-Induced Thrombocytopenia (HIT)

  • Laboratory diagnostics and interpretation / Maria Farm
    Laboratory evaluation of HIT, including immunological and functional assays, diagnostic algorithms, analytical limitations, and interpretation of test results in relation to clinical probability.
  • Clinical aspects and therapeutic management / TBD
    Clinical presentation, pathophysiology, and diagnostic assessment of HIT including differential diagnosis and evidence-based anticoagulant management.
  • Interactive discussion and case-based reflections
    Interactive session featuring clinical case discussions and deep dives into the complex interplay between laboratory findings and clinical decision-making.